Apraglutide (Synonyms: FE 203799) |
Catalog No.GC34473 |
L'apraglutide (FE 203799), un peptide synthétique de 33 acides aminés et un analogue du GLP-2 À action prolongée, améliore l'adaptation et la croissance intestinale linéaire dans un modèle de porcelet néonatal du syndrome de l'intestin court avec résection totale de l'iléon .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1295353-98-8
Sample solution is provided at 25 µL, 10mM.
Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum[1].
Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7[1]. Animal Model: NewbornDuroc piglets, 2-5 days old and weighing between 2-2.6 kg[1].
[1]. Slim GM, et al. Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum. JPEN J Parenter Enteral Nutr. 2019 Jan 6.
Average Rating: 5
(Based on Reviews and 21 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *